{'fraction_non_alphanumeric': 0.01171875, 'fraction_numerical': 0.0, 'mean_word_length': 6.328571428571428, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Bifidobacterium Genus in Colorectal Carcinoma Tissue in relation to Tumor Characteristics and Patient Survival

Evidence suggests that members of the Bifidobacterium genus may not only inhibit colorectal carcinogenesis, but also enhance the anti‐tumor immune response and efficacy of immunotherapy. We hypothesized that the amount of bifidobacteria in colorectal carcinoma tissue might be associated with distinctive clinical features, higher immune response to colorectal cancer, and favorable clinical outcome.